The Push Narrative and Why It Does Not Fit Lead Gen

Google and most agencies will tell you exact match is legacy and broad match plus AI Max is the future. The push narrative is consistent across Google’s UI recommendations, agency pitch decks, and conference content, and it has been accelerating since AI Max became generally available in April 2026. For lead-generation healthcare in 2026, exact match is not dead, it is the safer default, especially for accounts under 10K monthly spend.

The structural reason is that broader matching serves the platform more clearly than it serves the lead-gen advertiser. Broad match expands query coverage, which expands ad spend, which expands platform revenue. The advertiser’s question is different, does the expanded query coverage produce conversion volume that justifies the spend, or does it produce noise that increases CPA? For lead-gen healthcare with tight CPA targets and narrow lead quality requirements, the answer is often that broad match introduces variance without commensurate volume gain. Exact match preserves the intent precision that lead-gen healthcare relies on, and the precision matters more than the coverage. This piece gives the counter-argument with 2026 evidence so the practice can push back on the broad-match-everything pitch with data rather than instinct.

Coverage vs Control and Why Healthcare Picks Control

Broad match plus AI Max maximizes query coverage. Exact match maximizes control. The trade-off is real and the right choice depends on what the advertiser values more. For e-commerce with broad SKU inventory and forgiving conversion economics, coverage often wins, the cost of a mismatched query is low and the value of an unanticipated converting query is high. For healthcare lead gen, where lead quality and HIPAA compliance both require tight control, the calculus inverts.

Healthcare lead gen has narrow conversion definitions, a real evaluation booking is the goal and an information-seeking form fill is not. Broad match introduces queries the advertiser did not anticipate, and a meaningful fraction of those queries fall outside the narrow conversion definition. Worse, the queries that do convert may convert at lower lead quality, the form gets filled but the lead does not show or does not match the practice’s clinical scope. The right default for eye care is exact and phrase match with selective broad-match expansion as a deliberate test, not broad-match-first as the structural default. The companion negative keyword audit piece covers the negative-list discipline that any broad-match expansion requires.

For neuro-vision specifically, the control argument is stronger because the condition-named keyword space attracts wide off-intent query distributions. “Concussion” matches news searches, “TBI” matches movie titles, “long covid” matches symptom-research queries that may never convert. Exact match on the practice’s defined service queries (post-concussion vision therapy, neuro-optometric evaluation) preserves the intent precision while exact-match negatives or phrase-match negatives clean the off-intent distribution.

The Practitioner Consensus and the Healthcare Discount

Practitioner consensus for lead-gen accounts under 10K monthly spend supports exact match as the safer starting point (Psyche Digital, Feb 2026, among others). The consensus is well-evidenced, multiple agency reports across 2024 to 2026 converge on the finding that small lead-gen accounts perform better on exact and phrase than on broad, regardless of whether AI Max is layered on. The exact mechanism varies by account, but the directional finding is consistent.

AI Max’s 14 percent typical lift (Google’s official figure for accounts with heavy exact and phrase match) applies to all advertisers in aggregate. Lead-gen healthcare specifically often sees smaller or negative lift due to query-quality variance, the AI Max expansion produces queries that convert at lower rates than the existing exact-match base, and the cumulative effect drags weighted CVR down rather than up. For sub-10K monthly neuro-vision accounts running 5 to 25 conversions, the AI Max lift either does not materialize or appears as conversion-volume increase paired with CPA increase, which is not the trade-off the practice wanted.

The healthcare discount on aggregate match-type benchmarks is well-established for the same reasons that benchmarks for AI Max generally need a healthcare discount, healthcare campaigns rely more heavily on negative-list discipline than commercial campaigns, and broader matching erodes that discipline. The companion eye care benchmarks piece covers the comparative figures that frame this trade-off.

Five Red Flags in Match-Type Strategy

Five red flags signal a match-type strategy that needs review. First, the agency is pushing broad match for all campaigns without volume justification. Broad match requires 30-plus monthly conversions per campaign for Smart Bidding to optimize the broader query distribution reliably, and accounts below this threshold should not run broad match as the default match type. The blanket recommendation toward broad match is a tell that the agency is following Google’s pitch rather than the account’s data.

Second, broad match is enabled on accounts under 30 conversions per month, where Smart Bidding learning fails on the wider query distribution. Third, no exact and phrase match layer underneath broad match, the account is missing the intent-specific conversion data that exact match generates and that the bidding model uses as anchor signal. Fourth, the negative keyword list is not proportional to the broad-match aggressiveness, broader matching requires more aggressive negative-list maintenance, and accounts running broad match with quarterly negative reviews are under-investing in the discipline that broad match demands.

Fifth, “Google recommends broad match” is being taken as instruction rather than suggestion. The recommendation engine is deliberately optimistic about broader matching because that serves Google’s revenue goals. Treating it as instruction produces accounts that follow recommendations into worse performance. For the related red-flag inventory, see our search-term reports weekly piece, which covers the cadence that supports any expansion decision. For the related AI Max framing, see our AI Max eye care September 2026 piece.

Building the Match-Type Structure That Survives

Structure exact match on proven, converting queries (the queries that have demonstrated conversion in the last 90 days at acceptable CPA). Add phrase match for variations of the proven queries to capture intent-equivalent variations without expanding to off-intent territory. Reserve broad match for accounts that meet three conditions, 50-plus conversions per month, disciplined weekly negative-keyword review, and conversion values defined so Smart Bidding optimizes value rather than raw volume.

AI Max search term matching can substitute for broad match with better control for accounts that want some expansion without the negative-list maintenance burden of true broad match. AI Max’s expanded matching respects negatives and offers more control surfaces than broad match alone, which makes it the safer expansion option for accounts that have outgrown pure exact and phrase but cannot yet justify broad match. The companion Performance Max underperforms piece covers the parallel argument against PMax for lead gen.

For neuro-vision-specific application, start exact match on the defined service queries (post-concussion vision therapy, neuro-optometric evaluation, vision therapy after concussion, double vision after stroke), expand to phrase match for the natural variations, and treat any broader expansion as a deliberate test rather than a default. Document the testing protocol explicitly, broad match enabled on a single ad group for 4 to 6 weeks with weekly negative review. Measurement requires comparing the test ad group to the exact-match baseline rather than to its own pre-test performance, the comparison surfaces whether the broader matching actually improved the account or just added noise.

Specialty Vision’s Take on Match Types in 2026

Our view, “exact match is dead” is a push narrative from Google and from agencies that do not want to do the negative-keyword work that broad match actually requires. Exact match still produces the majority of predictable, profitable conversions in eye care lead gen, especially for sub-10K monthly accounts. The right default depends on account size and conversion volume, not on Google’s current promotional stance. We recommend exact and phrase match as the structural baseline for any neuro-vision account under 50 monthly conversions, with AI Max search term matching as the controlled expansion path when the practice is ready to test it. For the broader audit framework, see our 2026 PPC audit playbook.

The exact-match default also keeps the practice in control of which queries enter the auction, which matters more on PHI-adjacent neuro-vision pages than on consumer-eye-care pages where query expansion carries less downstream risk.